Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, research by Carnegie Mellon's Biomedical Engineering Department Head Bin He advances high-density electroencephalography (EEG) as ...
Apr 23, 2020
0
184
The race is on to develop a vaccine that can protect us from the COVID-19 pandemic. An impressive 115 vaccine candidates are currently being investigated, but it is still many months before a vaccine might be approved.
Apr 21, 2020
0
1
Nigerian President Muhammadu Buhari on Monday ordered a two-week extension to a lockdown in largest city Lagos, neighbouring Ogun state and capital Abuja, aimed at halting the spread of the coronavirus.
Apr 13, 2020
0
0
Coronavirus cases in Mumbai's densely populated Dharavi slum—one of Asia's biggest—have risen to 43 including four deaths, officials said Sunday, as they ramp up testing in a race to contain its spread.
Apr 12, 2020
0
6
Daily updated graphs illustrating the rising COVID-19 death rates in different countries raise hopes that we can understand the impact of the virus and work out how to stop it from spreading further. But when comparing countries ...
Apr 6, 2020
0
6
Since the global outbreak of COVID-19, researchers have scrambled to develop and share models which can predict how the virus will spread. This is inherently tricky, as we know so little about the disease, and a model is ...
Apr 3, 2020
0
2
An analysis of a large Swedish cohort revealed that breast density, microcalcifications, and masses are heritable features, and that breast density and microcalcifications were positively associated with a genetic predisposition ...
Apr 2, 2020
0
1
In the fight against neurodegenerative diseases such as frontotemporal dementia, Alzheimer's and Chronic Traumatic Encephalopathy, the tau protein is a major culprit. Found abundantly in our brain cells, tau is normally a ...
Apr 2, 2020
0
305
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...
Mar 30, 2020
0
0
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial ...
Mar 30, 2020
0
0
